Interactions between the epidermal growth factor receptor and type I protein kinase A: Biological significance and therapeutic implications

Clinical Cancer Research

Volumn 4, Issue 4, 1998, Pages 821-828

  Ciardiello, Fortunato ^a   Tortora, Giampaolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; AMPHIREGULIN; CETUXIMAB; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL GROWTH; ENZYME ACTIVITY; GENE OVEREXPRESSION; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENES, RAS; HUMANS; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0031943619     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (78)

1. Sporn, M. B., and Roberts, A. B. Autocrine secretion: ten years later. Ann. Intern. Med., 117: 408-414, 1992.
2. Aaronson, S. A. Growth factors and cancer. Science (Washington DC), 254: 1146-1153, 1991.
3. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
4. Saeki, T., Stromberg, K., Qi, C-F., Gullick, W. J., Tahara, E., Normanno, N., Ciardiello, F., Kenney, N., Johnson, G. R., and Salomon, D. S. Differential immunohistochemical detection of amphiregulin and cripto in normal colon and human colorectal tumors. Cancer Res., 52: 3467-3473, 1992.
5. Panico, L., D'Antonio, A., Salvatore, G., Mazza, E., Tortora, G., De Laurentiis, M., De Placido, S., Giordano, T., Merino, M., Salomon, D. S., Gullick, W. J., Pettinato, G., Bianco, A. R., and Ciardiello, F. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int. J. Cancer, 65: 51-56, 1996.
6. Ciardiello, F., Bianco, C., Normanno, N., Baldassarre, G., Pepe, S., Tortora, G., Bianco, A. R., and Salomon, D. S. Infection with a transforming growth factor α antisense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line. Int. J. Cancer, 54: 952-958, 1993.
7. Ciardiello, R, Tortora, G., Bianco, C., Selvam, M. P., Basolo, F., Fontanini, G., Pacifico, F., Normanno, N., Brandt, R., Persico, M. G., Salomon, D. S., and Bianco, A. R. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene, 9: 291-298, 1994.
8. Normanno, N., Bianco, C., Damiano, V., de Angelis, E., Selvam, M. P., Grassi, M., Magliulo, G., Tortora, G., Bianco, A. R., Mendelsohn, J., Salomon, D. S., and Ciardiello, F. Growth inhibition of human colon carcinoma cells by combinations of anti-EGF-related growth factor antisense oligonucleotides. Clin. Cancer Res., 2: 601-609, 1996.
9. Kenney, N. J., Saeki, T., Gottardis, M., Kim, N., Garcia-Morales, P., Martin, M. B., Normanno, N., Ciardiello, F., Day, A., Cutler, M. L., and Salomon, D. S. Expression of transforming growth factor α (TGFα) antisense mRNA inhibits the estrogen-induced production and the estrogen-induced proliferation of estrogen-responsive human breast cancer cells. J. Cell. Physiol., 156: 497-514, 1993.
10. Lacal, J. C., and Carnero, A. Regulation of ras proteins and their involvement in signal transduction pathways. Oncol. Rep., 1: 677-693, 1994.
11. Pawson, T. Protein modules and signalling networks. Nature (Lond.), 373: 573-579, 1995.
12. Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., and Bowtell, D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature (Lond.), 363: 83-85, 1993.
13. Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., and Schlessinger, J. Guanine-nucleotidereleasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (Lond.), 363: 85-88, 1993.
14. Gale, N. W., Kaplan, S., Lowenstein, E. J., Schlessinger, J., and Bar-Sagi, D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature (Lond.), 363: 88-92, 1993.
15. Wang, Z., and Moran, M. F. Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science (Washington DC), 272: 1935-1939, 1996.
16. Kannan, S., De Santis, M., Lohmeyer, M., Riese, D. J., Smith, G. H., Hynes, N. E., Seno, M., Brandt, R., Bianco, C., Persico, M. G., Kenney, N., Normanno, N., Martinez-Lacaci, I., Ciardiello, F., Stern, D. F., Gullick, W. J., and Salomon, D. S. Cripto enhances the tyrosine phosphorylation of She and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J. Biol. Chem., 272: 3330-3335, 1997.
17. Taylor, S. S., Buechler, J. A., and Yonemoto, W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem., 59: 971-1005, 1990.
18. Cho-Chung, Y. S., and Clair, T. The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol. Ther., 60: 265-288, 1993.
19. Cho-Chung, Y. S., Pepe, S., Clair, T., Budillon, A., and Nesterova, M. cAMP-dependent protein kinase: role in normal and malignant growth. Crit. Rev. Oncol. Hematol., 21: 33-61, 1995.
20. Miller, W. R., Watson, D. M. A., Jack, W., Chetty, U., and Elton, R. A. Tumor cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res. Treat., 26: 89-94, 1993.
21. Boshart, M., Welh, F., Nichols, M., and Schutz, G. The tissue-specific extinguisher locus TSE1 encodes a regulatory subunit of cAMP-dependent protein kinase. Cell, 66: 849-859, 1991.
22. Tortora, G., Budillon, A., Yokozaki, H., Clair, T., Pepe, S., Merlo, G., Rohlff, C., and Cho-Chung, Y. S. Retroviral vector-mediated overexpression of the RIIβ subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts. Cell Growth Differ., 5: 753-759, 1994.
23. Kim, S. N., Lee, G. R., Cho-Chung, Y. S., Park, S. D., and Hong, S. H. Overexpression of RIIβ regulatory subunit of protein kinase A induces growth inhibition and reverse-transformation in SK-N-SH human neuroblastoma cells. Int. J. Oncol., 8: 663-668, 1996.
24. Tortora, G., Ciardiello, F., Ally, S., Clair, T., Salomon, D. S., and Cho-Chung, Y. S. Site-selective 8-chloro-adenosine 3′,5′ monophosphate inhibits transformation and transforming growth factor α production in Ki-ras-transformed rat fibroblasts. FEBS Lett., 242; 363-367, 1989.
25. Shankar, V., Ciardiello, F., Kim, N., Derynck, R., Liscia, D. S., Merlo, G., Langton, B. C., Sheer, D., Callahan, R., Bassin, R. H., Lippman, M. E., Hynes, N., and Salomon, D. S. Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor α cDNA. Mol. Carcinog., 2: 1-11, 1989.
26. Ciardiello, F., Tortora, G., Kim, N., Clair, T., Ally, S., Salomon, D. S., and Cho-Chung, Y. S. 8-Cl-cAMP inhibits transforming growth factor α transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J. Biol. Chem., 265: 1016-1020, 1990.
27. Ciardiello, F., McGeady, M. L., Kim, N., Basolo, F., Hynes, N. E., Langton, B., Yokozaki, H., Saeki, T., Elliott, J., Masui, H., Mendelsohn, J., Soule, H., Russo, J., and Salomon, D. S. Transforming growth factor-α expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-α complementary DNA leads to transformation. Cell Growth Differ., 1: 407-420, 1990.
28. Ciardiello, F., Tortora, G., Pepe, S., Bianco, C., Baldassarre, G., Ruggiero, A., Bianco, C., Selvam, M. P., and Bianco, A. R. Reduction of RIα subunit of cAMP-dependent protein kinase expression induces growth inhibition of human mammary epithelial cells transformed by TGFα, c-Ha-ras, and c-erbB-2 genes. Ann. NY Acad. Sci., 698: 102-107, 1993.
29. Ennis, B. W., Valverius, E. M., Bates, S. E., Lippman, M. E., Bellot, F., Kris, R., Schlessinger, J., Masui, H., Goldenberg, A., Mendelsohn, J., and Dickson, R. B. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol. Endocrinol., 3: 1830-1838, 1989.
30. Ciardiello, F., Dixit, M., di Isernia, G., Damiano, V., Bianco, R., Bianco, A. R., Arteaga, C. L., and Tortora, G. Down-regulation of type I protein kinase A by transfection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector. Breast Cancer Res. Treat., in press, 1998.
31. Burgering, M. T., Pronk, G. J., van Weeren, P. C., Chardin, P., and Bos, J. L. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J., 12: 4211-4220, 1993.
32. Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M. J., and Sturgill, T. W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science (Washington DC), 262: 1065-1069, 1993.
33. Cook, S. J., and McCormick, F. Inhibition by cAMP of ras-dependent activation of raf. Science (Washington DC), 262: 1069-1072, 1993.
34. Gallo, A., Benusiglio, E., Bonapace, I. M., Feliciello, A., Cassano, S., Garbi, C., Musti, A. M., Gottesman, M. E., and Avvedimento, E. V. v-Ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A. Genes Dev., 6: 1621-1630, 1992.
35. Indolfi, C., Avvedimento, E. V., Di Lorenzo, E., Esposito, G., Rapacciuolo, A., Giuliano, P., Grieco, D., Cavuto, L., Stingone, A. M., Ciullo, I., Condorelli, L., and Chiariello, M. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat. Med., 3: 775-779, 1997.
36. Indolfi, C., Avvedimento, E. V., Rapacciuolo, A., Di Lorenzo, E., Esposito, G., Stabile, E., Feliciello, A., Mele, E., Giuliano, P., Condorelli, G. L., and Chiariello, M. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat. Med., 1: 541-545, 1995.
37. Tortora, G., Pepe, S., Bianco, C., Baldassarre, G., Budillon, A., Clair, T., Cho-Chung, Y. S., Bianco, A. R., and Ciardiello, F. The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene, 9: 3233-3240, 1994.
38. Byus, C. V., Klimpel, G. R., Lucas, D. O., and Russel, D. H. Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesis. Nature (Lond.), 268: 63-64, 1977.
39. Laxminarayana, D., Berrada, A., and Kammer, G. M. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J. Clin. Invest., 92: 2207-2214, 1993.
40. Tortora, G., Pepe, S., Cirafici, A. M., Ciardiello, F., Porcellini, A., Clair, T., Colletta, G., Cho-Chung, Y. S., and Bianco, A. R. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase. Cell Growth Differ., 4: 359-365, 1993.
41. Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G., and Pierotti, M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol., 13: 358-366, 1993.
42. Faux, M. C., and Scott, J. D. Molecular glue: kinase anchoring and scaffold proteins. Cell, 85: 9-12, 1996.
43. Nigg, E. A., Hilz, H., Eppenberger, H. M., and Dutly, F. Rapid and reversible translation of the catalytic subunit of cAMP-dependent protein type II from the Golgi complex to the nucleus. EMBO J., 4: 2801-2806, 1985.
44. Corbin, J. D., Keely, S. L., and Park, C. R. The distribution and dissociation of cyclic adenosine 3-5-monophosphate protein kinases in adipose, cardiac and other tissues. J. Biol. Chem., 250: 218-225, 1975.
45. Kapoor, C. L., and Cho-Chung, Y. S. Compartmentalization of regulatory subunits of cyclic adenosine 3′,5′-monophosphate-dependent protein kinases in MCF-7 human breast cancer cells. Cancer Res., 43: 295-302, 1983.
46. Meinkoth, J. L., Ji, Y., Taylor, S., and Feramisco, J. R. Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells. Proc. Natl. Acad. Sci. USA, 87: 9595-9599, 1990.
47. Skalhegg, B. S., Tasken, K., Hansson, V., Huitfeldt, H. S., Janhsen, T., and Lea, T. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science (Washington DC), 263: 84-87, 1994.
48. Pepe, S., Ruggiero, A., Tortora, G., Ciardiello, F., Garbi, C., Yokozaki, H., Cho-Chung, Y. S., Clair, T., Skalhegg, B. S., and Bianco, A. R. Flow-cytometric detection of the RIα subunit of type I cAMP-dependent protein kinase in human cells. Cytometry, 15: 73-79, 1994.
49. Tortora, G., Damiano, V., Bianco, C., Baldassarre, G., Bianco, A. R., Lanfrancone, L., Pelicci, P. G., and Ciardiello, F. The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene, 14: 923-928, 1997.
50. Mendelsohn, J. Potential clinical applications of anti-EGF receptor monoclonal antibodies. Cancer Cells, 7: 359-362, 1989.
51. Baselga, J., and Mendelsohn, J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res. Treat., 29: 127-138, 1994.
52. Masui, H., Kamrath, H., Apell, G., Houston, L. L., and Mendelsohn, J. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Cancer Res., 49: 3482-3488, 1989.
53. Arteaga, C. L., Hurd, S. D., Dugger, T. C., Winnier, A. R., and Robertson, J. B. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor α-Pseudomonas exotoxin 40 fusion protein. Cancer Res., 54: 4703-4709, 1994.
54. Kirk, J., Carmichael, J., Stratford, I. J., and Harris, A. L. Selective toxicity of TGF-α-PE40 to EGFR-positive cell lines: selective protec tion of low EGFR-expressing cell lines by EGF. Br. J. Cancer, 69: 988-994, 1994.
55. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., and Pastan, I. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin. Cancer Res., 1: 859-864, 1995.
56. Schmidt, M., and Wels, W. Targeted inhibition of tumor cell growth by a bispecific single-chain toxin containing an antibody domain and TGFα. Br. J. Cancer, 74: 853-862, 1996.
57. Buchdunger, E., Mett, H., Trinks, U., Regenass, U., Muller, M., Meyer, T., Beilstein, P., Wirz, B., Schneider, P., Traxler, P., and Lydon, N. 4,5-Bis(4-fluoroanilino)phthalimide: a selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity. Clin. Cancer Res., 1: 813-821, 1995.
58. Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., MacLeod, C., and Mendelsohn, J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem., 259: 7755-7760, 1984.
59. Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 44: 1002-1007, 1984.
60. Aboud-Pirak, E., Hurwitz, E., Pirak, M. E., Bellot, F., Schlessinger, J., and Sela, M. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J. Natl. Cancer Inst., 80: 1605-1611, 1988.
61. Modjtahedi, H., Eccles, S., Box, G., Styles, J., and Dean, C. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction. Br. J. Cancer, 67: 254-261, 1993.
62. Fan, Z., Baselga, J., Masui, H., and Mendelsohn, J. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus as-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res., 53: 4637-4642, 1992.
63. Baselga, J., Norton, L., Masui, H., Pandiella, A., Coplan, K., Miller, W. H., and Mendelsohn, J. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. Natl. Cancer Inst., 85: 1327-1333, 1993.
64. Goldstein, N. I., Prewett, M., Zuklys K., Rockwell, P., and Mendelsohn, J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res., 1: 1311-1318, 1995.
65. Falcey, J., Pfister, D., Cohen, R., Cooper, M., Bowden, C., Burtness, B., Mendelsohn, J., and Waksal, H. A study of anti-epidermal growth factor receptor (EGFr) monoclonal antibody C225 and cisplatin in patients (pts) with head and neck or lung carcinomas. Proc. Am. Soc. Clin. Oncol., 16: 1997.
66. Rohlff, C., Clair, T., and Cho-Chung, Y. S. 8-Cl-cAMP induces truncation and down-regulation of the RIα subunit and up-regulation of the RIIβ subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J. Biol. Chem., 268: 5774-5782, 1993.
67. Tagliaferri, P., Katsaros, D., Clair, T., Ally, S., Tortora, G., Neckers, L., Rubalcava, B., Parandoosh, Z., Chang, Y. A., Revanker, G. R., Crabtree, G. W., Robins, R. K., and Cho-Chung, Y. S. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cAMP analogs. Cancer Res., 48: 1642-1650, 1988.
68. Ally, S., Clair, T., Katsaros, D., Tortora, G., Yokozaki, H., Finch, R. A., Avery, T. L., and Cho-Chung, Y. S. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cAMP. Cancer Res., 49: 5650-5655, 1989.
69. Bianco, C., Tortora, G., Baldassarre, G., Caputo, R., Fontanini, G., Chinè, S., Bianco, A. R., and Ciardiello, F. 8-Chloro-cAMP inhibits autocrine and angiogenic growth factors production in human colorectal and breast cancer. Clin. Cancer Res., 3: 439-448, 1997.
70. Scala, S., Budillon, A., Zhan, Z., Cho-Chung, Y. S., Jefferson, J., Tsokos, M., and Bates, S. E. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J. Clin. Invest., 96: 1026-1034, 1995.
71. Tortora, G., Ciardiello, F., Pepe, S., Tagliaferri, P., Ruggiero, A., Bianco, C., Guarrasi, R., Miki, K., and Bianco, A. R. Phase I clinical study with 8-chloro-cAMP and evaluation of immunologic effects in cancer patients. Clin. Cancer Res., 1: 377-384, 1995.
72. Tortora, G., Yokozaki, H., Pepe, S., Clair, T., and Cho-Chung, Y. S. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA, 88: 2011-2015, 1991.
73. Yokozaki, H., Budillon, A., Tortora, G., Meissner, S., Beaucage, S. L., Miki, K., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res 53: 868-872, 1993.
74. Nesterova, M., and Cho-Chung, Y. S. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nat. Med., 1: 528-533, 1995.
75. Agrawal, S., Jiang, Z., Zhao, Q., Shaw, D., Cai, Q., Roskey, A., Channavajjala, L., Saxinger, C., and Zhang, R. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc. Natl. Acad. Sci. USA, 94: 2620-2625, 1997.
76. Ciardiello, F., Damiano, V., Bianco, C., di Isernia, G., Ruggiero, A., Caraglia, M., Tagliaferri, P., Baselga, J., Mendelsohn, J., Bianco, A. R., and Tortora, G. Cooperative antiproliferative effects of 8-Cl-cAMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. Clin. Cancer Res., 1: 161-167, 1995.
77. Ciardiello, F., Damiano, V., Bianco, R., Bianco, C., Fontanini, G., De Laurentiis, M., De Placido, S., Mendelsohn, J., Bianco, A. R., and Tortora, G. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J. Natl. Cancer Inst., 88: 1770-1776, 1996.
78. Tortora, G., di Isernia, G., Sandomenico, C., Bianco, R., Pomatico, G., Pepe, S., Bianco, A. R., and Ciardiello, F. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res., 57: 5107-5111, 1997.